—
Enteric-Coated, Activity-Standardized (in SPU/SU units): verification pending
We’re confirming the science for this compound before we publish a form ranking. Our team reviews every ranked page against peer-reviewed absorption data — this one is still under review, so we are not showing a score yet.
Check back soon. Rankings are reviewed by Dr. Brennan Commerford, D.C.
References
- Randomized controlled trial (n=133): enteric-coated serratiopeptidase significantly improved trismus and facial swelling vs placebo at day 4 after impacted third-molar surgery — a form-specific result for the enteric-coated formulation. PubMed
- Crossover randomized trial (n=24) using enteric-coated serrapeptase: significant reduction in cheek swelling and pain at days 2, 3, and 7 post-operatively vs placebo. PubMed
- Prospective randomized trial (n=66): the serrapeptase group showed ~50% reduction in ankle swelling by day 3 post-surgery vs control; the earliest randomized evidence supporting post-surgical swelling reduction with the enteric-coated enzyme. PubMed
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.